BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 17690600)

  • 1. Efficacy and safety of antidepressant monotherapy in the treatment of bipolar-II depression.
    Agosti V; Stewart JW
    Int Clin Psychopharmacol; 2007 Sep; 22(5):309-11. PubMed ID: 17690600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bipolar depression: treatment options.
    Yatham LN; Kusumakar V; Parikh SV; Haslam DR; Matte R; Sharma V; Kennedy S
    Can J Psychiatry; 1997 Aug; 42 Suppl 2():87S-91S. PubMed ID: 9288441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic depression: response to placebo, imipramine, and phenelzine.
    Stewart JW; McGrath PJ; Quitkin FM; Rabkin JG; Harrison W; Wager S; Nunes E; Ocepek-Welikson K; Tricamo E
    J Clin Psychopharmacol; 1993 Dec; 13(6):391-6. PubMed ID: 8120152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monotherapy versus combined treatment with second-generation antipsychotics in bipolar disorder.
    Ketter TA
    J Clin Psychiatry; 2008; 69 Suppl 5():9-15. PubMed ID: 19265635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bipolar disorder: how far are we from a rigorous definition and effective management?
    Emilien G; Septien L; Brisard C; Corruble E; Bourin M
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):975-96. PubMed ID: 17459551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of imipramine in psychotic versus nonpsychotic depression.
    Birkenhager TK; van den Broek WW; Mulder PG; Moleman P; Bruijn JA
    J Clin Psychopharmacol; 2008 Apr; 28(2):166-70. PubMed ID: 18344726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are treatment emergent suicidality and decreased response to antidepressants in younger patients due to bipolar disorder being misdiagnosed as unipolar depression?
    Berk M; Dodd S
    Med Hypotheses; 2005; 65(1):39-43. PubMed ID: 15893115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Why antidepressants are not antidepressants: STEP-BD, STAR*D, and the return of neurotic depression.
    Ghaemi SN
    Bipolar Disord; 2008 Dec; 10(8):957-68. PubMed ID: 19594510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship of open acute mania treatment to blinded maintenance outcome in bipolar I disorder.
    McElroy SL; Bowden CL; Collins MA; Wozniak PJ; Keck PE; Calabrese JR
    J Affect Disord; 2008 Apr; 107(1-3):127-33. PubMed ID: 17888516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zinc supplementation augments efficacy of imipramine in treatment resistant patients: a double blind, placebo-controlled study.
    Siwek M; Dudek D; Paul IA; Sowa-Kućma M; Zieba A; Popik P; Pilc A; Nowak G
    J Affect Disord; 2009 Nov; 118(1-3):187-95. PubMed ID: 19278731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does tachyphylaxis occur after repeated antidepressant exposure in patients with Bipolar II major depressive episode?
    Amsterdam JD; Shults J
    J Affect Disord; 2009 May; 115(1-2):234-40. PubMed ID: 18694599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Duration of antidepressant trials: clinical and research implications.
    Donovan SJ; Quitkin FM; Stewart JW; Ocepek-Welikson K; Harrison W; McGrath PJ; Nunes EV; Wager S; Tricamo E
    J Clin Psychopharmacol; 1994 Feb; 14(1):64-6. PubMed ID: 8151005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antidepressants and suicidal behavior in bipolar disorder.
    McElroy SL; Kotwal R; Kaneria R; Keck PE
    Bipolar Disord; 2006 Oct; 8(5 Pt 2):596-617. PubMed ID: 17042833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An outpatient evaluation of phenelzine and imipramine.
    Davidson J; Raft D; Pelton S
    J Clin Psychiatry; 1987 Apr; 48(4):143-6. PubMed ID: 3549705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mood state at study entry as predictor of the polarity of relapse in bipolar disorder.
    Calabrese JR; Vieta E; El-Mallakh R; Findling RL; Youngstrom EA; Elhaj O; Gajwani P; Pies R
    Biol Psychiatry; 2004 Dec; 56(12):957-63. PubMed ID: 15601606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paradoxical mood shifts to euthymia or hypomania upon withdrawal of antidepressant agents.
    McGrath PJ; Stewart JW; Tricamo E; Nunes EN; Quitkin FM
    J Clin Psychopharmacol; 1993 Jun; 13(3):224-5. PubMed ID: 8354742
    [No Abstract]   [Full Text] [Related]  

  • 17. Ziprasidone monotherapy in bipolar II depression: an open trial.
    Liebowitz MR; Salmán E; Mech A; Dunner D; Johnson AE; Akhtar J; Pratap R
    J Affect Disord; 2009 Nov; 118(1-3):205-8. PubMed ID: 19264363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient-rated troubling symptoms of depression instrument results correlate with traditional clinician- and patient-rated measures: a secondary analysis of a randomized, double-blind, placebo-controlled trial.
    Pandina GJ; Revicki DA; Kleinman L; Turkoz I; Wu JH; Kujawa MJ; Mahmoud R; Gharabawi GM
    J Affect Disord; 2009 Nov; 118(1-3):139-46. PubMed ID: 19321206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of short-term venlafaxine versus lithium monotherapy for bipolar II major depressive episode: a randomized open-label study.
    Amsterdam JD; Shults J
    J Clin Psychopharmacol; 2008 Apr; 28(2):171-81. PubMed ID: 18344727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Efficacy of antidepressants and thymoregulators in the long-term evolution of depression].
    Pringuey D; Robert P; Giacomoni F; Talichet L; Darcourt G
    Encephale; 1995 Mar; 21 Spec No 2():61-70. PubMed ID: 7588182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.